Bibliographic Details
| Title: |
Chemical and Photophysical Triggers for the Reduction of Pt(IV) Prodrugs for Anticancer Therapy. |
| Authors: |
Karges, Johannes |
| Superior Title: |
ChemNanoMat; Nov2023, Vol. 9 Issue 11, p1-11, 11p |
| Subject Terms: |
PLATINUM, PRODRUGS, METALS in medicine, NANOPARTICLES, BIOINORGANIC chemistry, INORGANIC chemistry, PLATINUM compounds |
| Abstract: |
Platinum(II) complexes are used in approximately 50% of chemotherapeutic treatments worldwide. Despite their undoubtful clinical success, these compounds are associated with severe side effects and poor tumor selectivity. To overcome these drawbacks, the development of platinum(IV) molecular prodrugs and nanoparticle formulations that remain stable and therapeutically inactive in a biological environment, but could be quickly reduced into the therapeutically active analogs through a specific trigger have been thought. Within this article, the mechanisms for chemical and photophysical triggers for the activation of platinum(IV) prodrugs have been critically reviewed. [ABSTRACT FROM AUTHOR] |
|
Copyright of ChemNanoMat is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
